Godavari Biorefineries secures Chinese Patent for cancer treatment compound
This patent covers a novel class of compounds that have exhibited strong inhibitory effects on cancer and cancer stem cells in vitro studies
Godavari Biorefineries has secured Chinese Patent for cancer treatment compound. China National Intellectual Property Administration (CNIPA) has granted patent entitled, ‘5-Hydroxy-1,4-Naphthalenedione for use in the Treatment of Cancer’.
This patent covers a novel class of compounds that have exhibited strong inhibitory effects on cancer and cancer stem cells in vitro studies. These compounds have demonstrated significant efficacy against multiple cancer cell types, including breast and prostate cancer.
Godavari Biorefineries is one of the manufacturers of ethanol based chemicals in India. Its diversified product portfolio comprises of bio-based chemicals, sugar, different grades of ethanol and power.
